.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer in 2014 for...
.On the heels of a phase 3 win that neglected to blow away real estate investors, Ironwood Pharmaceu...
.Do not quit Monte Rosa Rehabs currently. The Boston-based biotech is enjoying after authorizing a m...
.Invite to today's Chutes & Ladders, our summary of significant leadership hirings, firings and r...
.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has returned to the source of its antipsychotic powerhouse Vraylar searching for one more bl...
.GenSight Biologics is actually weeks far from losing amount of money. Once more. The biotech merely...
.Monopar Therapeutics is bouncing back a drug coming from the scrap heap of AstraZeneca's unusual he...
.With new data out on Arcus Biosciences' experimental HIF-2a prevention, one group of professionals ...
.After creating a genetics therapy partnership with Dyno Therapies in 2020, Roche is back for even m...